silver has been researched along with tamoxifen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abbas, H; El-Aassar, MR; El-Deeb, NM; Elmasry, SM; Ibrahim, OM | 1 |
Choi, YH; Nam, TJ; Ulagesan, S | 1 |
2 other study(ies) available for silver and tamoxifen
Article | Year |
---|---|
Alginate based tamoxifen/metal dual core-folate decorated shell: Nanocomposite targeted therapy for breast cancer via ROS-driven NF-κB pathway modulation.
Topics: Alginates; Breast Neoplasms; Drug Carriers; Female; Humans; MCF-7 Cells; Nanocomposites; Neoplasm Proteins; NF-kappa B; Reactive Oxygen Species; Silver; Tamoxifen | 2020 |
Cytotoxicity against human breast carcinoma cells of silver nanoparticles biosynthesized using Capsosiphon fulvescens extract.
Topics: Antineoplastic Agents; Apoptosis; Biotechnology; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chlorophyta; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Green Chemistry Technology; Humans; Indoles; Industrial Microbiology; Inhibitory Concentration 50; MCF-7 Cells; Metal Nanoparticles; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Particle Size; Plant Extracts; Silver; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Tamoxifen; X-Ray Diffraction | 2021 |